Alzheimerjeva bolezen je progresivna nevrološka motnja, ki povzroči degeneracijo in smrt možganskih celic, kar vodi do upada spomina, razmišljanja in razumevanja.
To je najpogostejši vzrok demence, ki predstavlja 60-80% vseh primerov.
Bolezen je na koncu usodna, povprečna pričakovana življenjska doba po diagnozi pa je 4-8 let, čeprav lahko nekateri ljudje z boleznijo živijo do 20 let.
Stopnja umrljivosti zaradi Alzheimerjeve bolezni se razlikuje glede na študijo in populacijo, ki se preučuje.
Po podatkih Alzheimerjevega združenja je Alzheimerjeva bolezen šesti najpogostejši vzrok smrti v Združenih državah in peti najpogostejši vzrok smrti za tiste, ki so stari 65 let in več.
Leta 2019 je bila Alzheimerjeva bolezen prijavljena kot osnovni vzrok smrti za 121.9444 ljudi v Združenih državah Amerike.
Pomembno je omeniti, da stopnja umrljivosti zaradi Alzheimerjeve bolezni ni izključno posledica bolezni same, ampak tudi zaradi zapletov in drugih zdravstvenih težav, ki nastanejo kot posledica bolezni.
Ko bolezen napreduje, lahko posamezniki imajo težave z vsakodnevnimi dejavnostmi, kot so prehranjevanje, kopanje in oblačenje, kar lahko privede do podhranjenosti, okužb in drugih zdravstvenih težav.
Poleg tega je pri osebah z Alzheimerjevo boleznijo večje tveganje za padce, pljučnico in druge okužbe.
Čeprav trenutno ni zdravila za Alzheimerjevo bolezen, so na voljo zdravljenja, ki lahko pomagajo obvladovati simptome in izboljšati kakovost življenja.
Raziskave se nadaljujejo, da bi razvili nove načine zdravljenja in na koncu našli zdravilo za to uničujočo bolezen.
Zhu B, Chen X, Li W, Zhou D: Effect of Alzheimer Disease on Prognosis of Intensive Care Unit (ICU) Patients: A Propensity Score Matching Analysis. Med Sci Monit. 2022, 28 (): e935397.
Almeida MC, Gomes Cde M, Nascimento LF: Spatial distribution of deaths due to Alzheimer's disease in the state of São Paulo, Brazil. Sao Paulo Med J. 2014, 132 (4): 199-204.
Aevarsson O, Svanborg A, Skoog I: Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998, 55 (9): 1226-32.
Breitner JC: Clinical genetics and genetic counseling in Alzheimer disease. Ann Intern Med. 1991, 115 (8): 601-6.
Iulita MF, Garzón Chavez D, Klitgaard Christensen M, Valle Tamayo N, Plana-Ripoll O, Rasmussen SA, Roqué Figuls M, Alcolea D, Videla L, Barroeta I, Benejam B, Altuna M, Padilla C, Pegueroles J, Fernandez S, Belbin O, Carmona-Iragui M, Blesa R, Lleó A, Bejanin A, Fortea J: Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome. JAMA Netw Open. 2022, 5 (5): e2212910.
Opozorilo: medicinsko
Ta spletna stran je namenjena samo izobraževalnim in informacijskim namenom in ne pomeni zagotavljanja zdravniških nasvetov ali strokovnih storitev.
Posredovani podatki se ne smejo uporabljati za diagnozo ali zdravljenje zdravstvenega problema ali bolezni, tisti, ki iščejo osebni zdravniški nasvet, pa se morajo posvetovati z licenciranim zdravnikom.
Upoštevajte, da je nevronska mreža, ki ustvarja odgovore na vprašanja, še posebej netočna, ko gre za številčno vsebino, na primer število ljudi, diagnosticiranih z določeno boleznijo.
Vedno poiščite nasvet svojega zdravnika ali drugega usposobljenega zdravstvenega delavca glede zdravstvenega stanja. Nikoli ne prezrite strokovnega zdravniškega nasveta ali odložite iskanja zaradi nečesa, kar ste prebrali na tej spletni strani. Če menite, da imate zdravniški nujen primer, pokličite 911 ali takoj pojdite v najbližjo urgenco. Ta spletna stran ali njena uporaba ne ustvarja nobenega odnosa med zdravnikom in bolnikom. Niti BioMedLib niti njeni zaposleni, niti kateri koli sodelavec na tej spletni strani ne daje nobenih izjav, izrecnih ali implicitnih, v zvezi z informacijami, ki so na voljo na tej spletni strani ali z njeno uporabo.
Opozorilo: avtorske pravice
Zakon o avtorskih pravicah za digitalno tisočletje iz leta 1998, 17 U.S.C. § 512 (DMCA) zagotavlja sredstva za lastnike avtorskih pravic, ki menijo, da material, ki se pojavlja na internetu, krši njihove pravice v skladu z ameriškim zakonom o avtorskih pravicah.
Če v dobri veri menite, da katera koli vsebina ali material, ki je na voljo v povezavi z našo spletno stranjo ali storitvami, krši vaše avtorske pravice, nam lahko (ali vašemu zastopniku) pošljete obvestilo, v katerem zahtevate odstranitev vsebine ali materiala ali blokiranje dostopa do njega.
Obvestila je treba poslati v pisni obliki po e-pošti (za e-poštni naslov glejte razdelek "Kontakt").
DMCA zahteva, da vaše obvestilo o domnevni kršitvi avtorskih pravic vključuje naslednje informacije: (1) opis avtorsko varovanega dela, ki je predmet domnevne kršitve; (2) opis domnevne vsebine, ki krši avtorske pravice, in informacije, ki so zadostne, da nam omogočijo iskanje vsebine; (3) kontaktne informacije za vas, vključno z vašim naslovom, telefonsko številko in e-poštnim naslovom; (4) izjavo, da imate v dobri veri prepričanje, da vsebina na način, o katerem se pritožujete, ni odobrena s strani imetnika avtorskih pravic ali njegovega zastopnika ali z delovanjem katerega koli zakona;
(5) vašo izjavo, podpisano pod kaznijo krivokletstva, da so informacije v uradnem obvestilu točne in da imate pooblastilo za uveljavljanje avtorskih pravic, ki naj bi bile kršene;
in (6) fizični ali elektronski podpis imetnika avtorskih pravic ali osebe, pooblaščene, da deluje v imenu imetnika avtorskih pravic.
Če ne vključite vseh zgornjih informacij, se lahko obravnava vaše pritožbe odloži.
Kontaktni podatki
Prosimo, pošljite nam e-pošto s kakršnim koli vprašanjem / predlogom.
How deadly is alzheimer?
Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die, leading to a decline in memory, thinking, and reasoning skills.
It is the most common cause of dementia, accounting for 60-80% of all cases.
The disease is ultimately fatal, with the average life expectancy after diagnosis being 4-8 years, although some people can live up to 20 years with the disease.
The mortality rate for Alzheimer's disease varies depending on the study and the population being examined.
According to the Alzheimer's Association, Alzheimer's disease is the sixth leading cause of death in the United States, and it is the fifth leading cause of death for those aged 65 and older.
In 2019, Alzheimer's disease was reported as the underlying cause of death for 121,9444 people in the United States.
It is important to note that the mortality rate for Alzheimer's disease is not solely due to the disease itself, but also due to complications and other health issues that arise as a result of the disease.
As the disease progresses, individuals may experience difficulty with activities of daily living, such as eating, bathing, and dressing, which can lead to malnutrition, infections, and other health problems.
Additionally, individuals with Alzheimer's disease may be at an increased risk of falls, pneumonia, and other infections.
While there is currently no cure for Alzheimer's disease, there are treatments available that can help manage symptoms and improve quality of life.
Research is ongoing to develop new treatments and ultimately find a cure for this devastating disease.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Približno
BioMedLib uporablja avtomatizirane računalnike (algoritme strojnega učenja) za ustvarjanje parov vprašanj in odgovorov.
Začeli smo s 35 milijoni biomedicinskih publikacij PubMed/Medline in spletnih strani RefinedWeb.
